AGP Executive Report
Last update: 7 hours agoHIV Treatment Supply: People living with HIV in Kenya are demanding a constant supply of quality ARVs after reports of expired medicines and inconsistent access, even as NASCOP and KEMSA insist there is no national shortage of key drugs like Nevirapine. Global Fund Partnership: Government leaders reaffirmed Kenya’s commitment to Global Fund support for HIV, TB and malaria, with Grant Cycle 8 set to prioritise stronger Social Health Authority systems, digital health and commodity security. Global Health Recognition: The UN Human Rights Council adopted a landmark resolution linking neglected tropical diseases to human rights, with Kenya among the African states pushing the move. Cancer Care Milestone: Kenyatta National Hospital performed Kenya’s first minimally invasive esophagectomy for esophageal cancer, a major step for specialised surgical and cancer treatment. Sickle Cell Burden: A Lancet study estimates 8.8 million children and adolescents in sub-Saharan Africa live with sickle cell disease in 2023, with Kenya listed among major contributors. Public Health & Safety: Kisumu launched a Sh306m non-motorised transport project and opened Baby Pendo Botanical Park, while Nairobi reported a fatal assault over a KSh 1,000 pub bill—both raising urgent questions on wellbeing and community safety. Health Systems & Access: Authorities rescued eight foreign nationals from an unlicensed rehab centre in Kajiado, citing serious rights and care violations. Research Leadership: Kenyan researcher Prof Kenneth Ngure was appointed to WHO’s STI Technical Advisory Group, boosting Kenya’s voice in global prevention strategies.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.